Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Acquired-Immune Deficiency Syndrome Dementia Complex

2-amino-5-phosphonovalerate has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research Excerpts

ExcerptRelevanceReference
" In addition, Tat, at similar concentrations, was toxic to human fetal neurons in culture."1.29Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. ( Brownstone, RM; Geiger, JD; Knudsen, BE; Magnuson, DS; Nath, A, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magnuson, DS1
Knudsen, BE1
Geiger, JD1
Brownstone, RM1
Nath, A1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity.
    Annals of neurology, 1995, Volume: 37, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; AIDS Dementia Complex; Animals; Cells, Cultured; Cerebral Cortex; Dose-

1995